Özlem Türeci

Özlem Türeci is a physician-scientist and co-founder of BioNTech who has pioneered personalized cancer immunotherapy approaches. Her research has advanced understanding of tumor-specific antigens and their application in therapeutic cancer vaccines. Türeci's work on neoantigen identification and mRNA vaccine technology has established new paradigms for individualized cancer treatment.

Özlem Türeci是医师科学家和BioNTech的联合创始人，她开创了个性化癌症免疫治疗方法。她的研究推进了对肿瘤特异性抗原及其在治疗性癌症疫苗中应用的理解。Türeci在新抗原鉴定和mRNA疫苗技术方面的工作为个体化癌症治疗建立了新范式。